Water-Drinking Test in Central Serous Chorioretinopathy
- PMID: 34084959
- PMCID: PMC8102945
- DOI: 10.4103/JOCO.JOCO_225_20
Water-Drinking Test in Central Serous Chorioretinopathy
Abstract
Purpose: To evaluate choroidal changes in central serous chorioretinopathy (CSCR) patients after water-drinking test (WDT).
Methods: This prospective study included treatment-naïve acute and chronic CSCR eyes and healthy controls. Intraocular pressure and optical coherence tomography measurements with choroidal vascular index (CVI) measurements were done at baseline. Patients were asked to drink 1 L of water, and tests were repeated at 15, 30, and 45 min.
Results: Fifty-six eyes from 42 patients were enrolled. Choroidal area, luminal area, and stromal area were higher at baseline in eyes with acute CSCR compared to healthy controls. Chronic CSCR eyes showed an increase in choroidal area and stromal area and a decrease in the luminal area at 15 min. There was a significant decrease in CVI at 30 and 45 min in chronic CSCR and CVI at 45 min in fellow eyes of acute CSCR. Repeated-measures analysis of variance (ANOVA) showed a significant change in central macular thickness in acute CSCR, choroidal thickness in fellow eyes of acute CSCR, stromal area, and total choroidal area in chronic CSCR. Mixed model ANOVA showed that the change in various choroidal parameters seen had no interaction with the eye type.
Conclusion: Although change in various parameters was seen in acute CSCR, chronic CSCR, and fellow eyes of acute CSCR following WDT, the change was not significantly different among the groups.
Keywords: Central serous chorioretinopathy; Choroidal vascular index; Optical coherence tomography; Water-drinking test.
Copyright: © 2021 Journal of Current Ophthalmology.
Conflict of interest statement
There are no conflicts of interest.
Figures


References
-
- Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta ophthalmol. 2008;86:126–45. - PubMed
-
- Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41:201–14. - PubMed
-
- Brandl C, Helbig H, Gamulescu MA. Choroidal thickness measurements during central serous chorioretinopathy treatment. Int Ophthalmol. 2014;34:7–13. - PubMed
LinkOut - more resources
Full Text Sources